Logo image of USAR

USA RARE EARTH INC (USAR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:USAR - US91733P1075 - Common Stock

16.98 USD
-0.76 (-4.28%)
Last: 1/13/2026, 3:11:05 PM
Fundamental Rating

1

USAR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 157 industry peers in the Metals & Mining industry. The financial health of USAR is average, but there are quite some concerns on its profitability. USAR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year USAR has reported negative net income.
In the past year USAR has reported a negative cash flow from operations.
USAR Yearly Net Income VS EBIT VS OCF VS FCFUSAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

With a Return On Assets value of -78.61%, USAR is not doing good in the industry: 91.72% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -78.61%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USAR Yearly ROA, ROE, ROICUSAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30

1.3 Margins

USAR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
USAR Yearly Profit, Operating, Gross MarginsUSAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

USAR has about the same amout of shares outstanding than it did 1 year ago.
USAR has a worse debt/assets ratio than last year.
USAR Yearly Shares OutstandingUSAR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M
USAR Yearly Total Debt VS Total AssetsUSAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.04 indicates that USAR is not in any danger for bankruptcy at the moment.
The Altman-Z score of USAR (3.04) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 3.04
ROIC/WACCN/A
WACCN/A
USAR Yearly LT Debt VS Equity VS FCFUSAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 16.51 indicates that USAR has no problem at all paying its short term obligations.
The Current ratio of USAR (16.51) is better than 94.90% of its industry peers.
USAR has a Quick Ratio of 16.51. This indicates that USAR is financially healthy and has no problem in meeting its short term obligations.
USAR has a better Quick ratio (16.51) than 94.90% of its industry peers.
Industry RankSector Rank
Current Ratio 16.51
Quick Ratio 16.51
USAR Yearly Current Assets VS Current LiabilitesUSAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

USAR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1072.40%.
EPS 1Y (TTM)-1072.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6598.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, USAR will show a very negative growth in Earnings Per Share. The EPS will decrease by -34.22% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1316.67%
EPS Next 2Y-32.41%
EPS Next 3Y-20.98%
EPS Next 5Y-34.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
USAR Yearly Revenue VS EstimatesUSAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 200M 400M 600M 800M
USAR Yearly EPS VS EstimatesUSAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

USAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for USAR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
USAR Price Earnings VS Forward Price EarningsUSAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USAR Per share dataUSAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.5 -1 -1.5 -2 -2.5

4.3 Compensation for Growth

A cheap valuation may be justified as USAR's earnings are expected to decrease with -20.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.41%
EPS Next 3Y-20.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for USAR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

USA RARE EARTH INC

NASDAQ:USAR (1/13/2026, 3:11:05 PM)

16.98

-0.76 (-4.28%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-31 2026-03-31
Inst Owners28.89%
Inst Owner Change0.29%
Ins Owners0.87%
Ins Owner Change0%
Market Cap2.36B
Revenue(TTM)N/A
Net Income(TTM)-254.15M
Analysts83.64
Price Target23.21 (36.69%)
Short Float %10.24%
Short Ratio1.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-96.08%
Min EPS beat(2)-216.26%
Max EPS beat(2)24.1%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)19.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)41.09%
EPS NY rev (1m)3.73%
EPS NY rev (3m)-492.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.52
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0
BVpS-0.34
TBVpS-0.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -78.61%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12528.1%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.51
Quick Ratio 16.51
Altman-Z 3.04
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3070.97%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1072.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6598.68%
EPS Next Y-1316.67%
EPS Next 2Y-32.41%
EPS Next 3Y-20.98%
EPS Next 5Y-34.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1181.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-118.33%
EBIT Next 3Y56.92%
EBIT Next 5Y79.48%
FCF growth 1Y40.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.76%
OCF growth 3YN/A
OCF growth 5YN/A

USA RARE EARTH INC / USAR FAQ

What is the fundamental rating for USAR stock?

ChartMill assigns a fundamental rating of 1 / 10 to USAR.


What is the valuation status of USA RARE EARTH INC (USAR) stock?

ChartMill assigns a valuation rating of 0 / 10 to USA RARE EARTH INC (USAR). This can be considered as Overvalued.


What is the profitability of USAR stock?

USA RARE EARTH INC (USAR) has a profitability rating of 0 / 10.


What is the financial health of USA RARE EARTH INC (USAR) stock?

The financial health rating of USA RARE EARTH INC (USAR) is 4 / 10.